| 02.04.2024 17:35 | ESKN, NOG, XLM | TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec | Alliance |
| 02.04.2024 15:50 | AVO | Further update on financing discussions | RNS |
| 29.02.2024 18:52 | ZYT, KDR, CGNR | EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding | Alliance |
| 29.02.2024 17:19 | AVO | Further update on financing discussions | RNS |
| 02.02.2024 14:06 | AVO | IN BRIEF: Advanced Oncotherapy eyes USD15 million tranche in February | Alliance |
| 09.01.2024 14:06 | AVO | IN BRIEF: Advanced Oncotherapy in advanced talks regarding loan | Alliance |
| 09.01.2024 09:00 | AVO | Update on Financing Discussions | RNS |
| 23.10.2023 18:51 | AVO | IN BRIEF: Advanced Oncotherapy in talks over possible cash injection | Alliance |
| 23.10.2023 07:00 | AVO | Update on Financing and Current Financial Position | RNS |
| 03.10.2023 18:29 | AVO | IN BRIEF: Advanced Oncotherapy results delayed, funding talks continue | Alliance |
| 29.09.2023 16:04 | AVO | Update on Financial Results | RNS |
| 17.07.2023 21:41 | AVO | Advanced Oncotherapy plans to raise up to GBP110 million | Alliance |
| 17.07.2023 07:00 | AVO | Recapitalisation and funding plan, update on FSP | RNS |
| 30.06.2023 19:54 | INSE, GCL, AVO | TRADING UPDATES: Jadestone Energy holds production and capex targets | Alliance |
| 30.06.2023 17:00 | AVO | Total Voting Rights | RNS |
| 30.06.2023 07:30 | AVO | Suspension - Advanced Oncotherapy PLC | RNS |
| 30.06.2023 07:15 | AVO | Update on financing, suspension of trading on AIM | RNS |
| 29.06.2023 13:35 | AVO | Holding(s) in Company | RNS |
| 29.06.2023 09:59 | AVO | Form 8.3 - Advanced Oncotherapy PLC | RNS |
| 28.06.2023 10:25 | AVO | Form 8.3 - Advanced Oncotherapy PLC | RNS |
| 27.06.2023 10:29 | AVO | Form 8.3 - Advanced Oncotherapy | RNS |
| 27.06.2023 10:25 | AVO | Form 8.3 - Advanced Oncotherapy | RNS |
| 26.06.2023 16:26 | AVO | Form 8.3 - Advanced Oncotherapy | RNS |
| 26.06.2023 10:57 | AVO | Partial conversion of Convertible Notes | RNS |
| 23.06.2023 11:05 | AVO | Holding(s) in Company | RNS |
| 23.06.2023 09:30 | AVO | Form 8.3 - Advanced Oncotherapy PLC | RNS |
| 20.06.2023 17:28 | AVO | Holding(s) in Company | RNS |
| 19.06.2023 17:56 | AVO | Partial conversion of Convertible Notes | RNS |
| 19.06.2023 13:48 | AVO | Form 8.3 - Advanced Oncotherapy PLC | RNS |
| 16.06.2023 18:23 | AVO | Issue of warrants | RNS |
| 13.06.2023 11:46 | AVO | Form 8.3 - Advanced Oncotherapy PLC | RNS |
| 02.06.2023 19:37 | AVO | IN BRIEF: Advanced Oncotherapy optimistic of securing further funding | Alliance |
| 31.05.2023 17:57 | AVO | Update on financing and convertible notes | RNS |
| 30.05.2023 10:42 | AVO | Form 8.3 - Advanced Oncotherapy Plc | RNS |
| 24.05.2023 17:54 | AVO | Form 8 (OPD) Advanced Oncotherapy plc | RNS |
| 24.05.2023 17:29 | AVO | Form 8.3 - Advanced Oncotherapy - Cosylab d.d. | RNS |
| 22.05.2023 14:59 | AVO | Form 8.3 - Advanced Oncotherapy plc | RNS |
| 19.05.2023 12:09 | AVO | Form 8.3 - Advanced Oncotherapy PLC | RNS |
| 17.05.2023 14:58 | AVO | Form 8.3 - Advanced Oncotherapy plc | RNS |
| 15.05.2023 21:10 | CGNR, VAST, CIZ | TRADING UPDATES: Online Blockchain keeping ADVFN at "arms length" | Alliance |
| 15.05.2023 11:36 | AVO | Update on Convertible Note & Loan Extension | RNS |
| 15.05.2023 09:19 | AVO | Form 8.3 - Advanced Oncotherapy Plc | RNS |
| 12.05.2023 12:53 | AVO | Form 8.3 - Advanced Oncotherapy - Minmetco Limited | RNS |
| 11.05.2023 17:14 | AVO | Form 8.3 - Advanced Oncotherapy - eQ Blue Planet | RNS |
| 11.05.2023 11:17 | AVO | Form 8.3 - Advanced Oncotherapy - Atlantic Cedar | RNS |
| 10.05.2023 11:34 | AVO | Form 8.3 - Advanced Oncotherapy plc | RNS |
| 09.05.2023 16:40 | AVO | Form 8.3 - Advanced Oncotherapy - Baltisches Haus | RNS |
| 09.05.2023 16:37 | AVO | Form 8.3 - Advanced Oncotherapy plc | RNS |
| 09.05.2023 16:36 | AVO | Form 8.3 - Advanced Oncotherapy plc | RNS |
| 05.05.2023 08:56 | AVO | FORM 8.3 - Advanced Oncotherapy | RNS |
| 05.05.2023 07:00 | AVO | Additional funding from Secured Convertible Note | RNS |
| 04.05.2023 17:01 | AVO | Form 8.3 - Advanced Oncotherapy Plc | RNS |
| 04.05.2023 15:55 | AVO | Change of Registered Office | RNS |
| 03.05.2023 18:19 | AVO | Rule 2.9 Announcement | RNS |
| 03.05.2023 16:28 | AVO | Form 8.3 - Advanced Oncotherapy PLC | RNS |
| 02.05.2023 18:19 | AVO | Form 8 (OPD) Advanced Oncotherapy plc | RNS |
| 18.04.2023 10:38 | AVO | Advanced Oncotherapy considers US sale of business to secure funding | Alliance |
| 18.04.2023 07:00 | AVO | Strategic review and formal sale process | RNS |
| 31.03.2023 18:05 | AVO | Holding(s) in Company | RNS |
| 20.03.2023 13:06 | AVO | IN BRIEF: Advanced Oncotherapy receives GBP1.2 million in funds | Alliance |
| 20.03.2023 12:36 | AVO | Update on Secured Convertible Note Facility | RNS |
| 01.03.2023 21:15 | ARV, GAL, BFSP | TRADING UPDATES: Galantas to raise GBP1.2 million in private placement | Alliance |
| 01.03.2023 14:54 | AVO | Secured Convertible Note Facility & other matters | RNS |
| 01.03.2023 14:05 | AVO | Second Price Monitoring Extn | RNS |
| 01.03.2023 14:00 | AVO | Price Monitoring Extension | RNS |
| 27.01.2023 16:53 | AVO | Hardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date | EQS |
| 18.01.2023 21:58 | SHG, SAV, IES | TRADING UPDATES: Bankers net assets drop; Invinity Energy wins funds | Alliance |
| 18.01.2023 14:00 | AVO | Operational update | RNS |
| 17.01.2023 15:10 | AVO | Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV | EQS |
| 30.12.2022 14:33 | AVO | IN BRIEF: Advanced Oncotherapy non-exec director buys 500,000 shares | Alliance |
| 30.12.2022 13:00 | AVO | Total Voting Rights | RNS |
| 30.12.2022 09:24 | AVO | Director/PDMR Shareholding | RNS |
| 29.12.2022 15:12 | AVO | Director/PDMR Shareholding | RNS |
| 28.12.2022 07:00 | AVO | Director/PDMR Shareholding | RNS |
| 23.12.2022 12:40 | AVO | Second Price Monitoring Extn | RNS |
